CINC - CinCor: 2022 Data Catalysts Will Derisk The Stock April, 07 2022 04:38 PM CinCor Pharma Inc. CINC's single asset is CIN-107 targeting hypertension. The company is well-funded after a solid IPO. A number of data catalysts will happen in 2022. For further details see: CinCor: 2022 Data Catalysts Will Derisk The Stock